Results
|
15461.
|
Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE study (SFCE). [electronic resource] by
- Bonaventure, Audrey
- Goujon-Bellec, Stéphanie
- Rudant, Jérémie
- Orsi, Laurent
- Leverger, Guy
- Baruchel, André
- Bertrand, Yves
- Nelken, Brigitte
- Pasquet, Marlène
- Michel, Gérard
- Sirvent, Nicolas
- Bordigoni, Pierre
- Ducassou, Stéphane
- Rialland, Xavier
- Zelenika, Diana
- Hémon, Denis
- Clavel, Jacqueline
Producer: 20120820
In:
Cancer causes & control : CCC vol. 23
Availability: No items available.
|
|
15462.
|
Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis. [electronic resource] by
- Kumar, Divya P
- Asgharpour, Amon
- Mirshahi, Faridoddin
- Park, So Hyun
- Liu, Sichen
- Imai, Yumi
- Nadler, Jerry L
- Grider, John R
- Murthy, Karnam S
- Sanyal, Arun J
Producer: 20160805
In:
The Journal of biological chemistry vol. 291
Availability: No items available.
|
|
15463.
|
|
|
15464.
|
|
|
15465.
|
Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours. [electronic resource] by
- Piha-Paul, S A
- Munster, P N
- Hollebecque, A
- Argilés, G
- Dajani, O
- Cheng, J D
- Wang, R
- Swift, A
- Tosolini, A
- Gupta, S
Producer: 20151109
In:
European journal of cancer (Oxford, England : 1990) vol. 51
Availability: No items available.
|
|
15466.
|
|
|
15467.
|
|
|
15468.
|
Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists. [electronic resource] by
- Crofts, F
- Rohatagi, S
- Pino, M
- DeLise, B
- Zhang, J
- Nguyen, M
- Guittin, P
- Barbellion, S
- Brunel, P
- Hofmann, T
- Schmidt, J
- Wong, M
- Lockey, P
- Lerman, S
- Clark, R
Producer: 20041209
In:
Birth defects research. Part B, Developmental and reproductive toxicology vol. 71
Availability: No items available.
|
|
15469.
|
|
|
15470.
|
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours. [electronic resource] by
- Brana, I
- Berger, R
- Golan, T
- Haluska, P
- Edenfield, J
- Fiorica, J
- Stephenson, J
- Martin, L P
- Westin, S
- Hanjani, P
- Jones, M B
- Almhanna, K
- Wenham, R M
- Sullivan, D M
- Dalton, W S
- Gunchenko, A
- Cheng, J D
- Siu, L L
- Gray, J E
Producer: 20150120
In:
British journal of cancer vol. 111
Availability: No items available.
|
|
15471.
|
Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752. [electronic resource] by
- Chen, XiuXiu
- Gong, LiHua
- Ou, RongYing
- Zheng, ZhenZhen
- Chen, JinYan
- Xie, FengFeng
- Huang, XiaoXiu
- Qiu, JianGe
- Zhang, WenJi
- Jiang, QiWei
- Yang, Yang
- Zhu, Hua
- Shi, Zhi
- Yan, XiaoJian
Producer: 20160628
In:
Gynecologic oncology vol. 140
Availability: No items available.
|